Biomea Fusion公司宣布,其研发的Icovamenib将在美国糖尿病协会(ADA)第86届科学会议上进行海报展示。这一重要学术活动将为研究者提供展示最新科研成果的平台。
Biomea Fusion公司宣布,其研发的Icovamenib将在美国糖尿病协会(ADA)第86届科学会议上进行海报展示。这一重要学术活动将为研究者提供展示最新科研成果的平台。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.